4 - WRAP TECHNOLOGIES, INC. (0001702924) (Issuer)
Insider Trading
Delayed 3mAll SEC insider transactions as they're filed.
Signed out · 3-min delay · Sign up for real-time
- Executive Chairman and CEO Cohen Scot was granted 4,000,000 shares (SEC Form 4)
- President and COO Novick Jared was granted 2,000,000 shares, increasing direct ownership by 1,307% to 2,153,012 units (SEC Form 4)
4 - WRAP TECHNOLOGIES, INC. (0001702924) (Issuer)
- Chief Financial Officer Roberts Brian K covered exercise/tax liability with 3,239 shares, decreasing direct ownership by 13% to 21,032 units (SEC Form 4) to cover taxes
4 - ONTO INNOVATION INC. (0000704532) (Issuer)
- Director De Angoitia Alfonso bought $9,978,488 worth of Series A Preference Shares (476,190 units at $20.95) (SEC Form 4)
4 - Liberty Latin America Ltd. (0001712184) (Issuer)
- President and CEO Altman Peter bought $872 worth of shares (800 units at $1.09), increasing direct ownership by 0.21% to 381,985 units (SEC Form 4)
4 - BioCardia, Inc. (0000925741) (Issuer)
- EVP, CRO, Commercial Bonanni Mark Emilio sold $100,941 worth of shares (3,385 units at $29.82), decreasing direct ownership by 25% to 10,420 units (SEC Form 4)
4 - OUTFRONT Media Inc. (0001579877) (Issuer)
- PRESIDENT AND CEO Kurtz George sold $4,164,832 worth of shares (20,000 units at $208.24), decreasing direct ownership by 0.26% to 7,816,019 units (SEC Form 4)
4 - CrowdStrike Holdings, Inc. (0001535527) (Issuer)
- Chief Financial Officer Chambers Rebecca sold $157,394 worth of shares (3,652 units at $43.10) as part of a pre-agreed trading plan and covered exercise/tax liability with 3,603 shares, decreasing direct ownership by 4% to 166,025 units (SEC Form 4) (withholding tax)
4 - VERACYTE, INC. (0001384101) (Issuer)
- EVP, General Counsel Mcguire Annie sold $140,212 worth of shares (3,254 units at $43.09) as part of a pre-agreed trading plan and covered exercise/tax liability with 3,215 shares, decreasing direct ownership by 5% to 131,160 units (SEC Form 4) (tax withholding)
4 - VERACYTE, INC. (0001384101) (Issuer)
- Chief Scientific & Med Officer Febbo Phillip G. covered exercise/tax liability with 3,639 shares and sold $564,410 worth of shares (13,110 units at $43.05) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 133,048 units (SEC Form 4) (withholding tax)
4 - VERACYTE, INC. (0001384101) (Issuer)